Professor Perry is one of the few research leaders in Orthopaedic Surgery, and is increasingly regarded as an international leader.
Professor Perry's research focuses on epidemiology and effectiveness research. He has an interest in 'big data' and clinical trials of orthopaedic interventions. His work largely, although not exclusively, focuses on children's orthopaedic disease - particularly Slipped Epiphysis, Perthes' disease and trauma. Currently he is the chief investigator on an NIHR-funded multi-centre prospective randomised superiority trial of an acute deformity correction versus pinning in situ for severe stable SCFE in children - The Big BOSS study.
Clinically, his interests are in hip diseases, foot diseases and trauma. His academic and surgical training has taken him to the University of Liverpool (Alder Hey), University of Warwick (University Hospital Coventry) and University of Toronto (SickKids Hospital).
He was appointed as ‘National Specialty Lead for Orthopaedic Clinical Trials’ by the Royal College of Surgeons of England (RCSEng), appointment to the 2020 “American British-Canadian (ABC) Travelling Orthopaedic Fellowship” and through his role as a mentor and co-lead/co-investigator to UK, US and Australian investigators on randomised controlled trials from NIHR, NIH and NHMRC.
Professor Perry's career has grown within the NIHR Academy, as Clinical Lecturer (2013-15) and Clinician Scientist (2015– 20). He has held academic appointments at the Universities of Warwick, Toronto, Oxford and Liverpool. These diverse and vibrant environments have provided unique opportunities to learn and collaborate with effective and efficient teams.
For his doctoral studies Professor Perry was awarded several honours, such as the Robert Jones Medal and Association Prize from the British Orthopaedic Association and the prestigious Hunterian Professorship, Royal College of Surgeons of England. As an NIHR Clinician Scientist he sought to inspire others to engage in research. In children’s orthopaedic surgery, he established a nationwide cohort to determine the epidemiology and outcomes of rare orthopaedic disease. This involved over 500 surgeons from 143 UK hospitals; the vast majority of surgeons had never before taken part in any NIHR research. This has sparked an explosion in UK orthopaedic research with the development of the Trauma and Orthopaedics Trials in Children (TOTs) collaborative. In association with the TOTs collaborative, he successfully led a team in Oxford, becoming Chief Investigator on three NIHR HTA trials; one of which (the FORCE Study) has recently completed follow-up. In 2019 he returned to Liverpool, where he has continued to develop academic surgery, with a further NIHR HTA trial funded, and other clinical investigators mentored to develop clinical trials. Professor Perry has a growing national and international research footprint, supporting NIHR doctoral students at the Universities of Leeds, Nottingham and Oxford and mentoring trial leads through the Universities of Sheffield, Duke (US) and Monash (Australia)
He has published over 40 peer-reviewed papers, and several textbook chapters. For his research has been awarded both the Hunterian Professorship by the Royal College of Surgeons of England, and the Robert Jones Gold Medal from the British Orthopaedic Association.
Professor Perry sits on the methodology committee for the Bone and Joint Journal, and is a reviewer for the NIHR EME programme, the BMJ, Trials, the Bone and Joint Journal and Acta Orthop.
Professor Perry also has ongoing involvement with the National Hip Fracture Database (NHFD) and Trauma Audit and Research Network (TARN).
An up to date list of his publications is available here - https://www.researchgate.net/profile/Daniel_Perry2
Prizes or Honours
- Hunterian Professor (Royal College of Surgeons of England, 2013)
- Robert Jones Gold Medal & Association Prize (British Orthopaedic Association , 2012)
- John Sharrard Prize (European Paediatric Orthopaedic Society (EPOS), 2012)